State of Wisconsin Investment Board Portfolio holdings
AUM
$40.9B
1-Year Return
24.31%
This Quarter Return
-3.65%
1 Year Return
+24.31%
3 Year Return
+99.94%
5 Year Return
+177.86%
10 Year Return
+427.44%
AUM
$48.2B
AUM Growth
-$3.58B
(-6.9%)
Cap. Flow
-$581M
Cap. Flow
% of AUM
-1.21%
Top 10 Holdings %
Top 10 Hldgs %
21.21%
Holding
2,541
New
398
Increased
831
Reduced
708
Closed
271
Top Buys
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$809M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$244M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$185M |
| 4 |
iShares National Muni Bond ETF
MUB
|
+$104M |
| 5 |
S&P Global
SPGI
|
+$75.1M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
+$199M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$154M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$118M |
| 4 |
Elevance Health
ELV
|
+$116M |
| 5 |
Microsoft
MSFT
|
+$88.6M |
Sector Composition
| 1 | Technology | 23.12% |
| 2 | Financials | 13.1% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 11.38% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1676
HF Sinclair
DINO
$9.57B
| $831K | ﹤0.01% |
20,844
-7,207
| -26% | -$287K |
|
1677
Fulcrum Therapeutics
FULC
$378M
| $825K | ﹤0.01% |
34,900
-22,400
| -39% | -$530K |
|
1678
Kodiak Sciences
KOD
$514M
| $821K | ﹤0.01% |
106,400
+43,518
| +69% | +$336K |
|
1679
Vanda Pharmaceuticals
VNDA
$265M
| $819K | ﹤0.01% |
72,400
| – | – |
|
1680
Reliance Steel & Aluminium
RS
$15.4B
| $818K | ﹤0.01% |
4,462
-3,136
| -41% | -$575K |
|
1681
Nkarta
NKTX
$143M
| $810K | ﹤0.01% |
71,200
+48,300
| +211% | +$549K |
|
1682
Liberty Latin America Class C
LILAK
$1.54B
| $807K | ﹤0.01% |
84,168
-6,105
| -7% | -$58.5K |
|
|
INBX
1683
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $802K | ﹤0.01% |
36,000
| – | – |
|
1684
OmniAb
OABI
$226M
| $799K | ﹤0.01% |
79,286
+51,754
| +188% | +$522K |
|
1685
Legend Biotech
LEGN
$6.24B
| $795K | ﹤0.01% |
21,877
+17,438
| +393% | +$634K |
|
1686
Ocugen
OCGN
$334M
| $788K | ﹤0.01% |
238,800
| – | – |
|
|
AMTI
1687
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $788K | ﹤0.01% |
104,800
+74,900
| +251% | +$563K |
|
|
SRNE
1688
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $785K | ﹤0.01% |
336,900
| – | – |
|
1689
Gogo Inc
GOGO
$1.38B
| $781K | ﹤0.01% |
41,000
+21,000
| +105% | +$400K |
|
|
AFMD
1690
DELISTED
Affimed
AFMD
| $780K | ﹤0.01% |
17,840
-2,200
| -11% | -$96.2K |
|
1691
Mersana Therapeutics
MRSN
$36.7M
| $779K | ﹤0.01% |
7,812
+4,948
| +173% | +$493K |
|
|
VXRT
1692
DELISTED
Vaxart
VXRT
| $779K | ﹤0.01% |
154,500
-49,700
| -24% | -$251K |
|
|
ALLK
1693
DELISTED
Allakos
ALLK
| $775K | ﹤0.01% |
136,000
+89,200
| +191% | +$508K |
|
1694
Praxis Precision Medicines
PRAX
$847M
| $774K | ﹤0.01% |
5,053
+2,953
| +141% | +$452K |
|
|
FRBN
1695
DELISTED
Forbion European Acquisition Corp. Class A Ordinary Shares
FRBN
| $772K | ﹤0.01% |
+77,464
| New | +$772K |
|
1696
Kezar Life Sciences
KZR
$29.3M
| $768K | ﹤0.01% |
4,620
-2,600
| -36% | -$432K |
|
1697
Instil Bio
TIL
$155M
| $768K | ﹤0.01% |
3,570
| – | – |
|
1698
Aspen Aerogels
ASPN
$560M
| $755K | ﹤0.01% |
21,900
+16,600
| +313% | +$572K |
|
1699
Immunovant
IMVT
$2.93B
| $755K | ﹤0.01% |
137,100
+87,800
| +178% | +$484K |
|
|
SGTX
1700
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
| $749K | ﹤0.01% |
39,202
| – | – |
|